Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
3.250
+0.120 (3.83%)
Nov 21, 2024, 1:19 PM EST - Market open
Savara Employees
Savara had 37 employees as of December 31, 2023. The number of employees increased by 9 or 32.14% compared to the previous year.
Employees
37
Change (1Y)
9
Growth (1Y)
32.14%
Revenue / Employee
n/a
Profits / Employee
-$2,241,514
Market Cap
557.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Community Health Systems | 61,000 |
Pharming Group | 382 |
SI-BONE | 344 |
ProKidney | 163 |
Monte Rosa Therapeutics | 133 |
PureTech Health | 90 |
Olema Pharmaceuticals | 74 |
Terns Pharmaceuticals | 66 |
SVRA News
- 8 days ago - Savara Announces Participation in Upcoming Healthcare Conferences - Business Wire
- 9 days ago - Savara Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 16 days ago - Savara to Present at the Guggenheim Inaugural Healthcare Innovation Conference - Business Wire
- 4 weeks ago - Savara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis (aPAP), is Highlighted on a New Episode of “The Balancing Act®” Airing on Lifetime® TV - Business Wire
- 4 weeks ago - Savara Announces New Employment Inducement Grant - Business Wire
- 7 weeks ago - Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting - Business Wire
- 7 weeks ago - Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Business Wire
- 2 months ago - Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately - Business Wire